Cost-effectiveness of Triple Therapy vs Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients After Methotrexate Failure
media
posted on 2021-03-25, 10:16 authored by SiNi Li, JianHe Li, LiuBao Peng, YaMin Li, XiaoMin Wan<p> </p>
<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
